{"id":"https://openalex.org/W3194050311","doi":null,"title":"Auswirkungen der Hypoxia Inducible Factor (HIF) - 1 - Hemmung durch Chetomin auf Hypoxie-abh\u00e4ngige Transkription und Strahlensensibilit\u00e4t in humanen Fibrosarkomzellen vom Typ HT 1080","display_name":"Auswirkungen der Hypoxia Inducible Factor (HIF) - 1 - Hemmung durch Chetomin auf Hypoxie-abh\u00e4ngige Transkription und Strahlensensibilit\u00e4t in humanen Fibrosarkomzellen vom Typ HT 1080","publication_year":2017,"publication_date":"2017-01-01","ids":{"openalex":"https://openalex.org/W3194050311","mag":"3194050311"},"language":"de","primary_location":{"id":"mag:3194050311","doi":null,"is_oa":false,"landing_page_url":"https://opus.bibliothek.uni-wuerzburg.de/files/15392/Diehlmann_Desiree_HIF1-Chetomin.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039625041","display_name":"D\u00e9sir\u00e9e Morgenroth","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"D\u00e9sir\u00e9e Morgenroth","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5039625041"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.27687527,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11176","display_name":"Radiation Therapy and Dosimetry","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3108","display_name":"Radiation"},"field":{"id":"https://openalex.org/fields/31","display_name":"Physics and Astronomy"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chetomin","display_name":"chetomin","score":0.8059999942779541},{"id":"https://openalex.org/keywords/hypoxia-inducible-factor-1","display_name":"HIF-1","score":0.8820000290870667},{"id":"https://openalex.org/keywords/hif-1-inhibition","display_name":"HIF-1 inhibition","score":0.9490000009536743},{"id":"https://openalex.org/keywords/p300-coactivator","display_name":"p300 coactivator","score":0.7879999876022339},{"id":"https://openalex.org/keywords/fibrosarcoma","display_name":"fibrosarcoma","score":0.8289999961853027},{"id":"https://openalex.org/keywords/ht1080-cells","display_name":"HT1080 cells","score":0.9620000123977661},{"id":"https://openalex.org/keywords/radiosensitivity","display_name":"radiosensitivity","score":0.6510000228881836},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.9120000004768372},{"id":"https://openalex.org/keywords/clonogenic-survival","display_name":"clonogenic survival","score":0.7570000290870667},{"id":"https://openalex.org/keywords/radiosensitization","display_name":"radiosensitization","score":0.6629999876022339},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.6650000214576721}],"concepts":[{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.6556329727172852},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4807055592536926},{"id":"https://openalex.org/C7836513","wikidata":"https://www.wikidata.org/wiki/Q1641506","display_name":"Hypoxia (environmental)","level":3,"score":0.4231835603713989},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.39317500591278076},{"id":"https://openalex.org/C16685009","wikidata":"https://www.wikidata.org/wiki/Q335057","display_name":"Andrology","level":1,"score":0.3335765600204468},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2735005021095276},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23812603950500488},{"id":"https://openalex.org/C540031477","wikidata":"https://www.wikidata.org/wiki/Q629","display_name":"Oxygen","level":2,"score":0.041378676891326904},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3194050311","doi":null,"is_oa":false,"landing_page_url":"https://opus.bibliothek.uni-wuerzburg.de/files/15392/Diehlmann_Desiree_HIF1-Chetomin.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7112265010","https://openalex.org/W7036234513","https://openalex.org/W2021401984","https://openalex.org/W7047696245","https://openalex.org/W1533192713","https://openalex.org/W1977242675","https://openalex.org/W1779574826","https://openalex.org/W2330504867","https://openalex.org/W2979838821","https://openalex.org/W3030254144"],"abstract_inverted_index":{"Hintergrund:":[0],"Die":[1,50,223],"Uberexpression":[2],"von":[3,33,53,144,168,209,213,218,236],"Hypoxia":[4],"Inducible":[5],"Factor":[6,92],"1":[7],"(HIF-1)":[8],"wird":[9],"mit":[10,35,58,62,113,121,191],"Tumorprogression":[11],"und":[12,88,146,150,170,204,217,232],"schlechter":[13],"Prognose":[14],"in":[15,61,111,196,241],"Zusammenhang":[16],"gebracht.":[17],"Wir":[18],"untersuchten,":[19],"ob":[20],"die":[21,40,80,166,177,199,229,234],"pharmakologische":[22],"Hemmung":[23],"des":[24],"Transkriptionsfaktors":[25],"HIF-1":[26,34],"mittels":[27,74],"Chetomin,":[28],"einem":[29],"Inhibitor":[30],"der":[31,82,133,142,179,182,193],"Interaktion":[32],"dem":[36],"Koaktivator":[37],"Protein":[38],"p300,":[39],"Hypoxie-induzierte":[41],"Strahlenresistenz":[42],"menschlicher":[43],"Fibrosarkomzellen":[44,240],"vom":[45],"Typ":[46],"HT":[47,66,70,238],"1080":[48,67,71,239],"beeinflusst.\r\nMethoden:":[49],"optimale":[51],"Dosis":[52],"Chetomin":[54,149,164,176,226],"wurde":[55],"durch":[56,225],"Versuchsreihen":[57],"Hypoxie-sensiblem":[59],"Promotor":[60],"destabilisiertem":[63],"EGFP-Vektor":[64],"transfizierten":[65],"HRE-Zellen":[68],"bestimmt.":[69],"Zellen":[72],"wurden":[73,96],"RT-PCR":[75,134],"sowie":[76,104],"Western":[77,161],"Blot":[78,162],"auf":[79,152,198,211,215,220],"Transkription":[81,231],"HIF-1-regulierten":[83],"Gene":[84],"Carboanhydrase":[85],"IX":[86],"(CA9)":[87],"Vascular":[89],"Endothelial":[90],"Growth":[91],"(VEGF)":[93],"untersucht.":[94],"Auserdem":[95],"sie":[97],"zur":[98],"Erstellung":[99],"klonogener":[100],"Assays":[101],"unter":[102,148],"normoxischen":[103],"hypoxischen":[105,237],"(0,1%":[106],"O2,":[107],"12":[108,127],"Stunden)":[109],"Bedingungen":[110],"vitro":[112],"0,":[114],"2,":[115],"5":[116],"oder":[117,122],"10":[118],"Gy":[119],"bestrahlt":[120],"ohne":[123],"Chetominbehandlung":[124],"(150":[125],"nM,":[126],"Stunden,":[128],"Vorbehandlung":[129],"4":[130],"Stunden).\r\nErgebnisse:":[131],"In":[132,172],"zeigte":[135],"sich":[136],"eine":[137],"signifikante":[138],"Reduktion":[139],"(Signifikanzniveau":[140],"p<0,05)":[141],"mRNS-Expression":[143],"CA9":[145,169],"VEGF":[147],"Hypoxie":[151],"44,4":[153],"+/-":[154,158],"7,2%":[155],"beziehungsweise":[156],"39,6":[157],"16,0%,":[159],"im":[160],"supprimierte":[163],"auch":[165],"Downstream-Genprodukte":[167],"VEGF.":[171],"den":[173],"Uberlebenskurven":[174],"erhohte":[175],"Wirksamkeit":[178],"Bestrahlung":[180],"wesentlich,":[181],"modifizierte":[183],"Sauerstoffeffekt":[184],"(modified":[185],"Oxygen":[186],"Enhancement":[187],"Ratio,":[188],"OER')":[189],"war":[190],"Ausnahme":[192],"50%":[194],"SF":[195],"Bezug":[197],"Kontrollen":[200],"bei":[201],"50%,":[202],"37%":[203],"10%":[205],"Relativem":[206],"Uberleben":[207],"(SF)":[208],"1,57":[210],"1,58,":[212],"1,56":[214],"1,42":[216],"1,38":[219],"1,22":[221],"reduziert.\r\nSchlussfolgerung:":[222],"HIF-1-Hemmung":[224],"reduziert":[227],"effektiv":[228],"Hypoxie-abhangige":[230],"verstarkt":[233],"Strahlensensibilitat":[235],"vitro.":[242]},"counts_by_year":[],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2021-08-30T00:00:00"}